Literature DB >> 18395993

Anandamide and neutrophil function in patients with fibromyalgia.

Ines Kaufmann1, Gustav Schelling, Christoph Eisner, Hans Peter Richter, Till Krauseneck, Michael Vogeser, Daniela Hauer, Patrizia Campolongo, Alexander Chouker, Antje Beyer, Manfred Thiel.   

Abstract

Fibromyalgia (FM) is a common stress-related painful disorder. There is considerable evidence of neuroimmunologic alterations in FM which may be the consequence of chronic stress and pain or causally involved in the development of this disorder. The endocannabinoid system has been shown to play a pivotal role in mammalian nociception, is activated under stressful conditions and can be an important signaling pathway for immune modulation. The endocannabinoid system could therefore be involved in the complex pathophysiology of FM. We tested this hypothesis by evaluating the effects of stress hormones and the endocannabinoid anandamide on neutrophil function in patients with FM. We determined plasma levels of catecholamines, cortisol and anandamide in 22 patients with primary FM and 22 age- and sex-matched healthy controls. Neutrophil function was characterized by measuring the hydrogen peroxide (H2O2) release (oxidative stress) and the ingestion capabilities of neutrophils (microbicidal function). FM patients had significantly higher norepinephrine and anandamide plasma levels. Neutrophils of FM patients showed an elevated spontaneous H2O2 production. The ability of neutrophils to adhere was negatively correlated with serum cortisol levels. Adhesion and phagocytosis capabilities of neutrophils correlated positively with anandamide plasma levels. In conclusion, patients with FM might benefit from pharmacologic manipulation of endocannabinoid signaling which should be tested in controlled studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395993     DOI: 10.1016/j.psyneuen.2008.02.009

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  16 in total

Review 1.  Endocannabinoid signalling in innate and adaptive immunity.

Authors:  Valerio Chiurchiù; Luca Battistini; Mauro Maccarrone
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

Review 2.  Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Authors:  Cecilia J Hillard
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

Review 3.  Brain-derived neurotrophic factor and exercise in fibromyalgia syndrome patients: a mini review.

Authors:  Boya Nugraha; Matthias Karst; Stefan Engeli; Christoph Gutenbrunner
Journal:  Rheumatol Int       Date:  2011-12-31       Impact factor: 2.631

Review 4.  Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.

Authors:  C J Hillard; K M Weinlander; K L Stuhr
Journal:  Neuroscience       Date:  2011-11-17       Impact factor: 3.590

5.  Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia.

Authors:  Shad B Smith; Dylan W Maixner; Roger B Fillingim; Gary Slade; Richard H Gracely; Kirsten Ambrose; Dmitri V Zaykin; Craig Hyde; Sally John; Keith Tan; William Maixner; Luda Diatchenko
Journal:  Arthritis Rheum       Date:  2012-02

Review 6.  Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.

Authors:  Joel E Schlosburg; Steven G Kinsey; Aron H Lichtman
Journal:  AAPS J       Date:  2009-01-29       Impact factor: 4.009

7.  The cannabinoid receptor 2 is critical for the host response to sepsis.

Authors:  Johannes Tschöp; Kevin R Kasten; Ruben Nogueiras; Holly S Goetzman; Cynthia M Cave; Lisa G England; Jonathan Dattilo; Alex B Lentsch; Matthias H Tschöp; Charles C Caldwell
Journal:  J Immunol       Date:  2009-06-12       Impact factor: 5.422

8.  Endocannabinoids and acute pain after total knee arthroplasty.

Authors:  Syed Azim; James Nicholson; Mario J Rebecchi; William Galbavy; Tian Feng; Ruth Reinsel; Nora D Volkow; Helene Benveniste; Martin Kaczocha
Journal:  Pain       Date:  2015-02       Impact factor: 7.926

9.  Biomarkers of endocannabinoid system activation in severe obesity.

Authors:  Jack C Sipe; T Michael Scott; Sarah Murray; Olivier Harismendy; Gabriel M Simon; Benjamin F Cravatt; Jill Waalen
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

10.  Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum.

Authors:  Yin Shou; Yang Yang; Ming-Shu Xu; Ying-Qian Zhao; Lin-Bao Ge; Bi-Meng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.